These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2491524)

  • 1. [Recovery of kidney function in a female patient with severe lupus nephropathy].
    Hernández Marrero D; Torres Ramírez A; Méndez Medina R; González-Posada JM; Losada Cabrera M; Lorenzo Sellares V; Maceira Cruz B
    An Med Interna; 1989 Apr; 6(4):209-11. PubMed ID: 2491524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of lupus nephritis associated with end-stage renal disease].
    Banfi G; Leoni A; Moroni G
    G Ital Nefrol; 2008; 25 Suppl 44():S68-S75. PubMed ID: 19048589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical course and prognostic factors in lupus nephropathy].
    Gamba G; Quintanilla L; del Bosque MD; Chew-Wong A; Correa-Rotter R
    Rev Invest Clin; 2000; 52(4):397-405. PubMed ID: 11061101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term prognosis of diffuse lupus nephritis.
    Ponticelli C; Zucchelli P; Moroni G; Cagnoli L; Banfi G; Pasquali S
    Clin Nephrol; 1987 Dec; 28(6):263-71. PubMed ID: 3327639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of end-stage renal disease due to lupus nephritis: comparison of six patients treated with both peritoneal and hemodialysis.
    Stock GG; Krane NK
    Adv Perit Dial; 1993; 9():147-51. PubMed ID: 8105910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
    Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
    Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical predictors of recovery and complications in the management of recent-onset renal failure in lupus nephritis: a Chinese experience.
    Liang L; Yang X; Xu H; Zhan Z; Ye Y; Yu X; Chen W
    J Rheumatol; 2004 Apr; 31(4):701-6. PubMed ID: 15088294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of lupus nephritis. A two-year prospective study.
    Doria A; Piccoli A; Vesco P; Vaccaro E; Marson P; De Silvestro G; Ossi E; Gambari P
    Ann Med Interne (Paris); 1994; 145(5):307-11. PubMed ID: 7985937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rapidly progressing lupus nephritis].
    Tareeva IE; Ianushkevich TN; Shilov EM; Milovanov IuS; Romanova MD
    Ter Arkh; 1990; 62(6):46-9. PubMed ID: 2218926
    [No Abstract]   [Full Text] [Related]  

  • 11. Unexpected recovery from longterm renal failure in severe diffuse proliferative lupus nephritis.
    Ross S; Benz K; Sauerstein K; Amann K; Dötsch J; Dittrich K
    BMC Nephrol; 2012 Aug; 13():81. PubMed ID: 22867270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. End-stage renal failure in systemic lupus erythematosus with nephritis.
    Correia P; Cameron JS; Ogg CS; Williams DG; Bewick M; Hicks JA
    Clin Nephrol; 1984 Dec; 22(6):293-302. PubMed ID: 6396007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasmapheresis combined with pharmacology in the treatment of lupus nephritis: a new therapeutic protocol].
    Russo GE; Bonello M; Vitaliano E; Bosco M; Maresca L; De Paola A; Tedaldi M; Bisciglia MF; Bauco B
    Clin Ter; 2000; 151(1):9-13. PubMed ID: 10822875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.
    Mok CC; Ying KY; Tang S; Leung CY; Lee KW; Ng WL; Wong RW; Lau CS
    Arthritis Rheum; 2004 Aug; 50(8):2559-68. PubMed ID: 15334470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term outcome of 93 patients with proliferative lupus nephritis.
    Moroni G; Quaglini S; Gallelli B; Banfi G; Messa P; Ponticelli C
    Nephrol Dial Transplant; 2007 Sep; 22(9):2531-9. PubMed ID: 17510096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systemic lupus erythematosus and end-stage chronic renal insufficiency. Therapeutic perspectives].
    Font J; Campistol JM
    Med Clin (Barc); 1989 Apr; 92(15):573-6. PubMed ID: 2666771
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
    Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of renal grafts in patients with lupus nephritis as cause of end-stage renal disease.
    Villaverde Verdejo P; Fernández Rivera C; Alonso Hernández A; Garcia Naveiro R; Cao Vilariño M; Tresancos Fernández C; Valdés Cañedo F
    Transplant Proc; 2005 Apr; 37(3):1426-7. PubMed ID: 15866625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment options in lupus nephritis.
    McLigeyo SO
    East Afr Med J; 1998 Oct; 75(10):609-13. PubMed ID: 10065198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of concurrent immunopathological mechanisms determining the pathology of severe lupus nephritis.
    Schwartz MM; Korbet SM; Katz RS; Lewis EJ
    Lupus; 2009 Feb; 18(2):149-58. PubMed ID: 19151117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.